Urothelial Papilloma of the Bladder(Clinicopathological Study of 32 Cases)

Hui WEN,Qiang DING,Zujun FANG,Guowei XIA
DOI: https://doi.org/10.3969/j.issn.1001-1420.2009.10.002
2009-01-01
Journal of Clinical Urology
Abstract:Objective:To study the clinicopathologic features of urothelial papillomas of the bladder,and to determine the risk of recurrence and progression.Methods:32 patients who were diagnosed with urothelial papilloma of the bladder were retrospectively studied using the criteria of the 1998 WHO/ISUP classification system.Pathological tissues were re-read,and clinical data,pathological characteristics and follow-up of these patients were summarized.Results:Simple papillary fronds were seen in all cases,some of the distinctive histologic features seen were changes in the umbrella cells:vacuolization(n = 4),apocrinelike morphology(n = 1),mucinous metaplasia (n=1) and eosinophilic syncytial morphology(n=l).Follow-up was available in 28 cases with a mean follow-up for those without evidence of progression of 28.9 months(range,3-61 months).2 patients(7.1%) developed recurrent papilloma 5 and 18 months after the initial diagnosis of papilloma;1 of two patients also showed progression to noninvasive low-grade urothelial carcinoma(LGUC)at the time of recurrence(18 months).2 patients (7.1%) progressed to highe grade disease:1 to noninvasive LGUC(11 months after the original diagnosis) and 1 to papillary urothelial neoplasm of low malignant potential at 33 months and noninvasive low-grade urothelial carcinoma at 41 months from the initial diagnosis of papilloma.None of the patients demonstrated progression to either lamina propria(T_1) or muscularis propria(T_2) invasion.2 patients died of unrelated causes.None of the patients died of bladder cancer.Conclusions:Patients with urothelial papillomas have a low incidence of recurrence and rarely progress to develop urothelial carcinoma.It seems reasonable to avoid labeling these patients as having cancer. It remains to be studied whether and when patients with papillomas who have no evidence of recurrence or progression no longer need to be followed.
What problem does this paper attempt to address?